Aratana Therapeutics develops innovative therapies for the animal health industry.
Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 31, 2013 | Series C | $12M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Midwest Venture Alliance | — | Series C |
Women's Capital Connection | — | Series C |